Connect with us

Cannabis News

Georgia Medical Marijuana Regulators Approve New Dispensary License As More Patients Register For Program

Published

on

“We will likely open up an application option for our production licensees, which means more access for patients.”

Author: Alander Rocha, Georgia Recorder

Georgia’s Medical Cannabis Access Commission approved a new dispensary license Wednesday, bringing the statewide total to 19, after a high patient enrollment threshold that triggered expansion under state law.

The board’s executive director, Andrew Turnage, said the program passed the 25,000 active patient mark some time ago, which allowed the board to approve the additional license. The board voted unanimously to grant a distribution license to FFD Georgia Holdings for a location in Atlanta. The company was the only applicant.

“I always like to share the update when it comes to the number of registered patients because we will likely open up an application option for our production licensees, which means more patient access,” Turnage told the board.

The program is also on track to accept additional licenses, with the number of active patients now at 33,314, moving toward the 35,000 threshold. The law authorizes the commission to issue additional distribution licenses after the 25,000 mark is reached by 10,000 patients.

But despite some progress, the public comment period was dominated by urgent and frustrated expressions from speakers who said the program’s scope is restrictive and limits access and effectiveness. The main complaints centered on product restrictions and stringent qualification requirements, with patients, advocates and other citizens calling for changes that would require legislative action.

The Georgia program, created a decade ago, limits participation to patients with certain conditions, including cancer or seizure disorders. But for some conditions, state law requires that the diagnosis be severe or end-stage.

Lawmakers have considered expanding the program in recent years, and a House study group is examining Georgia’s medical marijuana policies.

Dr. Elmore Alexander, medical director of US 420 Doc, an online service that offers cannabis card reviews, said Georgia’s low-THC oil program lacks the necessary delivery methods to adequately treat patients with complex conditions. The program is “not a mercy program,” he said, and currently banned methods, such as smoke inhalation, could help patients with sudden onset of symptoms like post-traumatic stress disorder.

“I don’t have enough products to take care of (my patients). I don’t have enough,” Alexander said, adding that the state needs to expand the program to include more products that address different conditions.

Several speakers, including former Rep. Micah Gravley, a key figure in the passage of Georgia’s cannabis law, called for the removal of the “serious and terminal” caveats that currently apply to many conditions. They argued that these vague conditions create confusion for doctors because they are not medically based and prevent patients from accessing treatment before their conditions become terminal.

Gravley, who said the state supports expanding the program, said the program’s limited scope was due to a lack of industry knowledge among lawmakers at the time the law was passed.

“I think you had a lot of legislators who were very cautious, who were very nervous to do this, and they really saw the tone and the tenor of the parents their children were putting down, the caregivers were testifying about family members, and so they went out on a limb. Unfortunately, at that time, the limb was too short,” Gravley said.

This story was first published by the Georgia Recorder.

Marijuana Moment is made possible with the help of readers. If you rely on our pro-cannabis journalism to stay informed, consider a monthly Patreon pledge.

Continue Reading

Cannabis News

Maximizing cannabis yields with intercanopy and subcanopy lighting

Published

on

By







Continue Reading

Cannabis News

Transportation Groups Warn Feds Of Marijuana Rescheduling’s ‘Consequences’ For Drug Testing Of Truck Drivers And Pilots

Published

on

By

A coalition of transportation and safety organizations said they have “serious safety concerns” about the Trump administration’s move to federally regulate marijuana.

Led by the American Trucking Association, the groups sent a letter to federal officials Monday asking them to take steps to ensure truck drivers, pilots, transit operators and other safety-sensitive workers continue to be tested for cannabis.

“If employers do not take the necessary steps to preserve the ability of security-sensitive transportation workers to test for marijuana, this change could have significant consequences for the safety of passengers and the entire transportation industry,” wrote Acting Attorney General Todd Blanche, Drug Enforcement Administration (DEA) Administrator Terrance Cole, Health and Human Services Secretary Robert F. Kennedy, and Transportation Secretary J.

The organizations said they understand that federal officials are being “urgently” reorganized under an executive order from President Donald Trump, that they are “deeply concerned that the current process does not adequately take into account agencies responsible for transportation safety or protecting the traveling public” and that they want the agencies to “work together.” ongoing cannabis redistricting hearings and rulemaking process to address these concerns.

In May, the Department of Transportation (DOT) issued new guidelines saying just that Truck drivers, airline pilots and other safety-sensitive workers still cannot use medical marijuana without penalty despite the Trump administration’s move to reschedule.

“Marijuana use is incompatible with safety-sensitive functions,” the department said.

Medical review officers (MROs) who receive drug test results indicating cannabis use cannot rule them out as negative for illegal substance use, even if an employee claims it was a result of state-licensed medical marijuana.

“Currently, there is no way for an MRO to verify that a laboratory-confirmed marijuana drug test result is positive when an employee claims the positive was caused by a state-licensed marijuana product,” the DOT said, explaining that after the reprogramming, medical marijuana dispensed under state law “does not” constitute a drug approved by the Food and Drug Administration (FDA).

The transportation groups said in the new letter that the DOT’s drug-testing program “is in accordance with the Department of Health and Human Services’ (HHS) Mandatory Guidelines for Federal Workplace Drug Testing Programs and HHS-certified laboratories.”

“While DOT has expressed its intention to continue testing marijuana, a commitment we greatly appreciate, it is unclear whether DOT will retain its ability to rely on HHS procedures and certifications after the rescheduling,” they wrote. “Without this alignment, DOT may retain the authority to conduct testing, but lack the scientific and procedural infrastructure to do so.”

“Practically, this would mean that truck and bus drivers, pilots, flight attendants, air traffic controllers, air mechanics, railroad workers, dispatchers and signal workers, transit operators and pipeline workers could continue to perform high-risk safety roles without a reliable means of verifying that they are not actively using marijuana. It relies on controlled substance testing to identify end use and prevent potentially impaired individuals from fulfilling their safety-related obligations. While the planning could create legal or regulatory loopholes, the regulated employer-based drug testing agency warned that the final rules should not jeopardize marijuana testing for safety-sensitive transportation workers.”

“Regardless of the broader policy goals of the review, the federal government should not move forward to preserve transportation drug testing programs and mitigate the risks of increased and unchecked deterioration of our roads, railroads, public transportation systems, pipelines, airspace, and maritime corridors,” the letter says.

The organizations specifically ask federal officials to:

  • Support long-term marijuana testing for all safety-sensitive transportation workers;
  • Confirm the authority of DOT-regulated employers to perform such tests;
  • Ensure HHS laboratory certification and testing guidelines remain available and aligned with DOT’s safety mission; and
  • Establish a coordinated federal strategy to address the transportation security implications of rescheduling.

“The public and the workers who keep our transportation system running safely deserve a process that ensures these safeguards are firmly in place before any final action is taken,” he said. the letter he says

Earlier this month, the House Appropriations Committee approved a provision to allow federal officials to continue requiring government employees and security-sensitive employees, such as truck drivers and airline pilots must be drug tested for marijuana, “regardless of any future change in legal status or schedule.”

This was followed by a press conference organized by prohibitionist groups and a drug-testing industry association, where both Republican lawmakers joined the proclamation. “Cut” to marijuana rescheduling by asserting that safety-sensitive transportation workers can still be punished for testing positive for THC.

Legislators and abolitionist activists argued that moving marijuana to Schedule III would lead to a 1986 executive order signed by President Ronald Reagan defining illegal drugs under the Controlled Substances Act (CSA) in relation to the use of cannabis by truck drivers and other airline employees.

Last October, Transportation Secretary Sean Duffy suggested that President Donald Trump was “putting pressure” on rescheduling cannabis.arguing that marijuana is “truly addictive” and that policy reform on the issue sends a “dangerous” message.

“At a time when the culture is encouraging and celebrating the use of marijuana, we’re not talking about risk,” Duffy said.

Marijuana Moment is made possible with the help of readers. If you rely on our pro-cannabis journalism to stay informed, consider a monthly Patreon pledge.

Continue Reading

Cannabis News

Experts say THC percentage is the wrong way to shop for cannabis

Published

on

By


Continue Reading
Advertisement

Trending

Copyright © 2021 The Art of MaryJane Media